[Current status of the prevention of pulmonary embolism].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003374:Coumarins / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D011464:Epoprostenol / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000517:prevention & control*; D013931:Thromboxanes / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014682:Vena Cava, Inferior / Q000601:surgery*
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D003374:Coumarins; D013931:Thromboxanes; D014665:Vasodilator Agents; D004176:Dipyridamole; D006493:Heparin; D011464:Epoprostenol; D002994:Clofibrate; D001241:Aspirin
Lo stato attuale della prevenzione dell'embolia polmonare.